{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,10]],"date-time":"2026-02-10T19:21:07Z","timestamp":1770751267476,"version":"3.50.0"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2016,9,2]],"date-time":"2016-09-02T00:00:00Z","timestamp":1472774400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Urologe"],"published-print":{"date-parts":[[2017,2]]},"DOI":"10.1007\/s00120-016-0219-x","type":"journal-article","created":{"date-parts":[[2016,9,2]],"date-time":"2016-09-02T08:24:16Z","timestamp":1472804656000},"page":"172-179","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Candidurie! Was nun?","Candiduria! What now?"],"prefix":"10.1007","volume":"56","author":[{"given":"H.","family":"Hof","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2016,9,2]]},"reference":[{"key":"219_CR1","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1128\/CMR.00076-09","volume":"23","author":"JM Achkar","year":"2010","unstructured":"Achkar JM, Fries BC (2010) Candida infections of the genitourinary tract. Clin Microbiol Rev 23:253\u2013273","journal-title":"Clin Microbiol Rev"},{"key":"219_CR2","unstructured":"AWMF (2010) S\u20113 Leitlinie AWMF-Register-Nr.\u00a0043\/044. Harnwegsinfektionen. Epidemiologie, Diagnostik, Therapie und Management unkomplizierter bakterieller ambulant erworbener Harnwegsinfektionen bei erwachsenen Patienten. Langfassung 17. Juni 2010"},{"key":"219_CR3","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1128\/AAC.46.3.828-833.2002","volume":"46","author":"I Bekersky","year":"2002","unstructured":"Bekersky I, Fielding RM, Dressler DE et\u00a0al (2002) Pharmacokinetics, excretion, and mass balance of liposomal amphotericin B (AmBisome) and amphotericin B deoxycholate in humans. Antimicrob Agents Chemother 46:828\u2013833","journal-title":"Antimicrob Agents Chemother"},{"key":"219_CR4","first-page":"873","volume":"35","author":"E Bergogne-Berezin","year":"1987","unstructured":"Bergogne-Berezin E, Berthelot G, Muller-Serieys C (1987) Present status of nitroxoline. Pathol Biol (Paris) 35:873\u2013878","journal-title":"Pathol Biol (Paris)"},{"key":"219_CR5","first-page":"879","volume":"35","author":"B Cancet","year":"1987","unstructured":"Cancet B, Amgar A (1987) Activit\u00e9 antifongique de la nitroxoline in vitro. R\u00e9sultats cliniques pr\u00e9liminaires. Pathol Biol (Paris) 35:879\u2013881","journal-title":"Pathol Biol (Paris)"},{"key":"219_CR6","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1007\/s10096-007-0427-9","volume":"27","author":"SC Chen","year":"2008","unstructured":"Chen SC, Tong ZS, Lee OC et\u00a0al (2008) Clinician response to Candida organisms in the urine of patients attending hospital. Eur J Clin Microbiol Infect Dis 27:201\u2013208","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"219_CR7","doi-asserted-by":"crossref","first-page":"4289","DOI":"10.1128\/AAC.05056-14","volume":"59","author":"S Costa-de-Oliveira","year":"2015","unstructured":"Costa-de-Oliveira S, Miranda IM, Silva-Dias A et al (2015) Ibuprofen potentiates the in vivo antifungal activity of fluconazole against Candida albicans murine infection. Antimicrob Agents Chemother 59:4289\u20134292","journal-title":"Antimicrob Agents Chemother"},{"key":"219_CR8","doi-asserted-by":"publisher","first-page":"1403","DOI":"10.1128\/AAC.05025-11","volume":"56","author":"CS Danby","year":"2012","unstructured":"Danby CS, Boikov D, Rautemaa-Richardson R et al (2012) Effect of pH on in vitro susceptibility of Candida glabrata and Candida albicans to 11 antifungal agents and implications for clinical use. Antimicrob Agents Chemother 56:1403\u20131406. doi: 10.1128\/AAC.05025-11","journal-title":"Antimicrob Agents Chemother"},{"key":"219_CR9","doi-asserted-by":"crossref","first-page":"2944","DOI":"10.1016\/j.transproceed.2010.08.019","volume":"42","author":"J Delgado","year":"2010","unstructured":"Delgado J, Calvo N, Gomis A (2010) Candiduria in renal transplant recipients: incidence, clinical repercussion, and treatment indication. Transplant Proc 42:2944\u20132946","journal-title":"Transplant Proc"},{"key":"219_CR10","first-page":"307","volume":"15","author":"D Demontrond","year":"1986","unstructured":"Demontrond D, Steinmetzt P, Bernard PF (1986) Infections urinaires \u00e0 levures. Traitement par la nitroxoline chez 15 patients. Bull Soc Fr Mycol Med 15:307\u2013310","journal-title":"Bull Soc Fr Mycol Med"},{"key":"219_CR11","doi-asserted-by":"crossref","first-page":"3341","DOI":"10.1128\/AAC.49.8.3341-3346.2005","volume":"49","author":"DT Dorsthorst te","year":"2005","unstructured":"Dorsthorst te DT, Verweij PE, Meis JF et\u00a0al (2005) Relationship between in vitro activities of amphotericin B and flucytosine and pH for clinical yeast and mold isolates. Antimicrob Agents Chemother 49:3341\u20133346","journal-title":"Antimicrob Agents Chemother"},{"key":"219_CR12","first-page":"207","volume":"3","author":"A Dufour","year":"1979","unstructured":"Dufour A, Bollack C (1979) De la p\u00e9n\u00e9tration de la nitroxoline dans le parenchyme prostatique. Essai th\u00e9rapeutique. J\u00a0Urol Nephrol 3:207\u2013212","journal-title":"J Urol Nephrol"},{"issue":"Suppl 6","key":"219_CR13","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1093\/cid\/cir112","volume":"52","author":"JF Fisher","year":"2011","unstructured":"Fisher JF, Sobel JD, Kauffman CA et al (2011) Candida urinary tract infections-treatment. Clin Infect Dis 52(Suppl 6):457\u2013466","journal-title":"Clin Infect Dis"},{"key":"219_CR14","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1046\/j.1469-0691.2003.00711.x","volume":"9","author":"JF Fisher","year":"2003","unstructured":"Fisher JF, Woeltje K, Espinel-Ingroff A (2003) Efficacy of a single intravenous dose of amphotericin B for Candida urinary tract infections: further favorable experience. Clin Microbiol Infect 9:1024\u20131027","journal-title":"Clin Microbiol Infect"},{"key":"219_CR15","first-page":"294","volume":"18","author":"J Focht","year":"1995","unstructured":"Focht J, N\u00f6sner K (1995) In-vitro-Wirksamkeit von Nitroxolin gegen Candida. Extr Urol 18:294\u2013296","journal-title":"Extr Urol"},{"key":"219_CR16","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1093\/jac\/36.6.1067","volume":"36","author":"IW Fong","year":"1995","unstructured":"Fong IW (1995) The value of a single amphotericin B bladder washout in candiduria. J\u00a0Antimicrob Chemother 36:1067\u20131071","journal-title":"J Antimicrob Chemother"},{"key":"219_CR17","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1111\/j.1439-0507.2012.02201.x","volume":"56","author":"S Helbig","year":"2013","unstructured":"Helbig S, Achkar JM, Jain N et\u00a0al (2013) Diagnosis and inflammatory response of patients with candiduria. Mycoses 56:61\u201369","journal-title":"Mycoses"},{"key":"219_CR18","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1111\/j.1439-0507.1991.tb00669.x","volume":"34","author":"JM Hern\u00e1ndez Molina","year":"1991","unstructured":"Hern\u00e1ndez Molina JM, Llos\u00e1 J, Ventosa A (1991) In vitro activity of nitroxoline against clinical isolates of Candida species. Mycoses 34:323\u2013325","journal-title":"Mycoses"},{"key":"219_CR19","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1111\/1469-0691.12165","volume":"19","author":"JM Herrero-Mart\u00ednez","year":"2013","unstructured":"Herrero-Mart\u00ednez JM, Lumbreras C, Manrique A et al (2013) Epidemiology, risk factors and impact on long-term pancreatic function of infection following pancreas-kidney transplantation. Clin Microbiol Infect 19:1132\u20131139","journal-title":"Clin Microbiol Infect"},{"key":"219_CR20","doi-asserted-by":"crossref","unstructured":"Hof H, Bertsch D, Passek D, Schwarz R. (2016) Nitroxolin \u2013 eine Option zur antibiotischen Therapie von Harnwegsinfektionen. (eingereicht)","DOI":"10.1007\/s00120-016-0218-y"},{"key":"219_CR21","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1055\/s-0034-1393691","volume":"43","author":"H Hof","year":"2014","unstructured":"Hof H, Sch\u00fctt S (2014) Nachweis von Candida spp. bei Patienten in hohem Alter. Was nun? Klinikarzt 43:372\u2013375","journal-title":"Klinikarzt"},{"key":"219_CR22","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1038\/mi.2013.72","volume":"6","author":"MA Ingersoll","year":"2013","unstructured":"Ingersoll MA, Albert ML (2013) From infection to immunotherapy: host immune responses to bacteria at the bladder mucosa. Mucosal Immunol 6:1041\u20131053","journal-title":"Mucosal Immunol"},{"key":"219_CR23","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.1128\/AAC.46.6.1773-1780.2002","volume":"46","author":"DM Kuhn","year":"2002","unstructured":"Kuhn DM, George T, Chandra J et\u00a0al (2002) Antifungal susceptibility of Candida biofilms: unique efficacy of amphotericin B lipid formulations and echinocandins. Antimicrob Agents Chemother 46:1773\u20131780","journal-title":"Antimicrob Agents Chemother"},{"key":"219_CR24","first-page":"735","volume":"33","author":"A Lenzner","year":"1983","unstructured":"Lenzner A (1983) Orale Behandlung von Pilzerkrankungen des Harntraktes mit Nitroxolin. Therapiewoche 33:735\u2013738","journal-title":"Therapiewoche"},{"key":"219_CR25","first-page":"47","volume-title":"Invasive Mykosen in der Intensivmedizin \u2013 ein Leitfaden f\u00fcr die Praxis mit Fallbeispielen","author":"C Lichtenstern","year":"2011","unstructured":"Lichtenstern C, Wolff M (2011) Management invasiver Mykosen in der Intensivmedizin. In: Weigand MA, Hoppe-Tichy T (Hrsg) Invasive Mykosen in der Intensivmedizin \u2013 ein Leitfaden f\u00fcr die Praxis mit Fallbeispielen. Uni-med, Bremen, S\u00a047\u201366"},{"key":"219_CR26","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1007\/s00101-009-1655-4","volume":"59","author":"C Lichtenstern","year":"2010","unstructured":"Lichtenstern C, Swoboda S, Hirschburger M et\u00a0al (2010) Update: invasive fungal infections: diagnosis and treatment in surgical intensive care medicine. Anaesthesist 59:30\u201352","journal-title":"Anaesthesist"},{"key":"219_CR27","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1586\/14787210.5.2.277","volume":"5","author":"AN Malani","year":"2007","unstructured":"Malani AN, Kauffman CA (2007) Candida urinary tract infections: treatment options. Expert Rev Anti Infect Ther 5:277\u2013284","journal-title":"Expert Rev Anti Infect Ther"},{"key":"219_CR28","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1128\/AAC.43.6.1383","volume":"43","author":"KA Marr","year":"1999","unstructured":"Marr KA, Rustad TR, Rex JH et\u00a0al (1999) The trailing end point phenotype in antifungal susceptibility testing is pH dependent. Antimicrob Agents Chemother 43:1383\u20131386","journal-title":"Antimicrob Agents Chemother"},{"key":"219_CR29","first-page":"265","volume":"15","author":"A Michel-Nguyen","year":"1986","unstructured":"Michel-Nguyen A, Nourrit J, Penaud A, Nicoli RM (1986) Nitroxoline et antifongiques traditionnels: comparaison de leur activit\u00e9 antifongique contre 238 souches de levures. Bull Soc Fr Mycol Med 15:265\u2013268","journal-title":"Bull Soc Fr Mycol Med"},{"key":"219_CR30","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1155\/2005\/385768","volume":"16","author":"LE Nicolle","year":"2005","unstructured":"Nicolle LE (2005) Complicated urinary tract infection in adults. Can J Infect Dis Med Microbiol 16:349\u2013360","journal-title":"Can J Infect Dis Med Microbiol"},{"issue":"e1","key":"219_CR31","first-page":"e50","volume":"62","author":"PG Pappas","year":"2016","unstructured":"Pappas PG, Kauffman CA, Andes DR et\u00a0al (2016) Clinical practice guideline for the management of Candidiasis: 2016 update by the infectious diseases society of America. Clin Infect Dis 62(e1):e50","journal-title":"Clin Infect Dis"},{"key":"219_CR32","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1128\/AAC.39.3.707","volume":"39","author":"C Pelletier","year":"1995","unstructured":"Pelletier C, Prognon P, Bourlioux P (1995) Roles of divalent cations and pH in mechanism of action of nitroxoline against Escherichia coli strains. Antimicrob Agents Chemother 39:707\u2013713","journal-title":"Antimicrob Agents Chemother"},{"key":"219_CR33","first-page":"C11","volume":"9","author":"MS Rishpana","year":"2015","unstructured":"Rishpana MS, Kabbin JS (2015) Candiduria in catheter associated urinary tract infection with special reference to biofilm production. J\u00a0Clin Diagn Res 9:C11\u20133","journal-title":"J Clin Diagn Res"},{"key":"219_CR34","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1186\/1471-2334-10-245","volume":"10","author":"R Rivera-Sanchez","year":"2010","unstructured":"Rivera-Sanchez R, Delgado-Ochoa D, Flores-Paz RR et al (2010) Prospective study of urinary tract infection surveillance after kidney transplantation. BMC Infect Dis 10:245","journal-title":"BMC Infect Dis"},{"key":"219_CR35","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1007\/s00129-013-3271-2","volume":"46","author":"S Singer","year":"2013","unstructured":"Singer S, Oberdorfer K, Schwarz R et\u00a0al (2013) Kalkulierte Antibiotikatherapie von Harnwegsinfektionen bei \u00e4lteren Frauen \u2013 Stellenwert von Ciprofloxacin und anderen Chinolonen. Gynakologe 46:847\u2013857","journal-title":"Gynakologe"},{"key":"219_CR36","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1517\/17425255.2011.615309","volume":"7","author":"M Sinnollareddy","year":"2011","unstructured":"Sinnollareddy M, Peake SL, Roberts MS et\u00a0al (2011) Pharmacokinetic evaluation of fluconazole in critically ill patients. Expert Opin Drug Metab Toxicol 7:1431\u20131440","journal-title":"Expert Opin Drug Metab Toxicol"},{"issue":"Suppl 6","key":"219_CR37","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1093\/cid\/cir109","volume":"52","author":"JD Sobel","year":"2011","unstructured":"Sobel JD, Fisher JF, Kauffman CA et al (2011) Candida urinary tract infections-epidemiology. Clin Infect Dis 52(Suppl 6):433\u2013436","journal-title":"Clin Infect Dis"},{"key":"219_CR38","doi-asserted-by":"crossref","first-page":"6021","DOI":"10.1128\/AAC.01484-12","volume":"56","author":"A Sobke","year":"2012","unstructured":"Sobke A, Klinger M, Hermann B et al (2012) The urinary antibiotic 5\u2011nitro-8-hydroxyquinoline (Nitroxoline) reduces the formation and induces the dispersal of pseudomonas aeruginosa biofilms by chelation of iron and zinc. Antimicrob Agents Chemother 56:6021\u20136025","journal-title":"Antimicrob Agents Chemother"},{"key":"219_CR39","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1111\/j.1439-0507.2011.02076.x","volume":"55","author":"S Tobudic","year":"2012","unstructured":"Tobudic S, Kratzer C, Lassnigg A et\u00a0al (2012) Antifungal susceptibility of Candida albicans in biofilms. Mycoses 55:199\u2013204","journal-title":"Mycoses"},{"key":"219_CR40","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1016\/j.ijid.2008.10.012","volume":"13","author":"FF Tuon","year":"2009","unstructured":"Tuon FF, Amato VS, Penteado Filho SR (2009) Bladder irrigation with amphotericin B and fungal urinary tract infection-systematic review with meta-analysis. Int J Infect Dis 13:701\u2013706","journal-title":"Int J Infect Dis"},{"key":"219_CR41","first-page":"C15","volume":"8","author":"J Udayalaxmi","year":"2014","unstructured":"Udayalaxmi J, Jacob S, D\u2019Souza D (2014) Comparison between virulence factors of Candida albicans and non-albicans species of Candida isolated from genitourinary tract. J Clin Diagn Res 8:C15\u20137","journal-title":"J Clin Diagn Res"},{"key":"219_CR42","doi-asserted-by":"crossref","first-page":"e188","DOI":"10.1016\/j.ijid.2010.11.004","volume":"15","author":"R Valdez-Ortiz","year":"2011","unstructured":"Valdez-Ortiz R, Sifuentes-Osornio J, Morales-Buenrostro LE et al (2011) Risk factors for infections requiring hospitalization in renal transplant recipients: a cohort study. Int J Infect Dis 15:e188\u2013e196","journal-title":"Int J Infect Dis"},{"issue":"Suppl 1","key":"219_CR43","doi-asserted-by":"crossref","first-page":"51","DOI":"10.2165\/11315640-000000000-00000","volume":"69","author":"P Viale","year":"2009","unstructured":"Viale P (2009) Candida colonization and candiduria in critically ill patients in the intensive care unit. Drugs 69(Suppl 1):51\u201357","journal-title":"Drugs"},{"key":"219_CR44","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1128\/AAC.02147-13","volume":"58","author":"FM Wagenlehner","year":"2014","unstructured":"Wagenlehner FM, M\u00fcnch F, Pilatz A et\u00a0al (2014) Urinary concentrations and antibacterial activities of nitroxoline at 250 milligrams versus trimethoprim at 200 milligrams against uropathogens in healthy volunteers. Antimicrob Agents Chemother 58:713\u2013721","journal-title":"Antimicrob Agents Chemother"},{"issue":"Suppl 2","key":"219_CR45","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1111\/j.1439-0507.1996.tb00529.x","volume":"39","author":"A Wildfeuer","year":"1996","unstructured":"Wildfeuer A, Laufen H, Schmalreck AF et\u00a0al (1996) Fluconazole: comparison of pharmacokinetics, therapy and in vitro susceptibility of yeasts. Mycoses 39(Suppl 2):51\u201357","journal-title":"Mycoses"}],"container-title":["Der Urologe"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00120-016-0219-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00120-016-0219-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00120-016-0219-x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00120-016-0219-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,13]],"date-time":"2019-09-13T00:33:24Z","timestamp":1568334804000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00120-016-0219-x"}},"subtitle":["Zur Therapie von Harnwegsinfektionen durch Candida","Therapy of urinary tract infections with Candida"],"short-title":[],"issued":{"date-parts":[[2016,9,2]]},"references-count":45,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2017,2]]}},"alternative-id":["219"],"URL":"https:\/\/doi.org\/10.1007\/s00120-016-0219-x","relation":{},"ISSN":["0340-2592","1433-0563"],"issn-type":[{"value":"0340-2592","type":"print"},{"value":"1433-0563","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,9,2]]}}}